Skip to Main Content

D.C. Diagnosis is STAT’s weekly newsletter about the politics and policy of health and medicine. Sign up here to receive it in your inbox.

It’s been a very rocky year for the Biotechnology Innovation Organization


When Michelle McMurry-Heath took over BIO, the sprawling organization representing some 1,000 drug companies in Washington, she vowed to transform the organization’s image in this town. That transformation threatened to tear the organization apart.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!


Create a display name to comment

This name will appear with your comment

There was an error saving your display name. Please check and try again.